 Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to:  The final amount of charges resulting from the planned North American asset realignment and the Company’s ability to realize anticipated savings and operational benefits from the asset realignment;  Our ability to achieve the strategic and other objectives relating to the acquisition of Spartech Corporation, including any expected synergies;  Our ability to successfully integrate Spartech and achieve the expected results of the acquisition, including, without limitation, the acquisition being accretive;  Disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future;  The financial condition of our customers, including the ability of customers (especially those that may be highly leveraged and those with inadequate liquidity) to maintain their credit availability;  The speed and extent of an economic recovery, including the recovery of the housing market;  Our ability to achieve new business gains;  The effect on foreign operations of currency fluctuations, tariffs, and other political, economic and regulatory risks;  Changes in polymer consumption growth rates in the markets where we conduct business;  Changes in global industry capacity or in the rate at which anticipated changes in industry capacity come online;  Fluctuations in raw material prices, quality and supply and in energy prices and supply;  Production outages or material costs associated with scheduled or unscheduled maintenance programs;  Unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters;  An inability to achieve or delays in achieving or achievement of less than the anticipated financial benefit from initiatives related to working capital reductions, cost reductions, employee productivity goals, and an inability to raise or sustain prices for products or services;  An inability to raise or sustain prices for products or services;  An inability to maintain appropriate relations with unions and employees;  The inability to achieve expected results from our acquisition activities;  Our ability to continue to pay cash dividends;  The amount and timing of repurchases of our common shares, if any; and  Other factors affecting our business beyond our control, including, without limitation, changes in the general economy, changes in interest rates and changes in the rate of inflation.  The above list of factors is not exhaustive.  We undertake no obligation to publicly update forward-looking statements, whether as a result of new information, future events or otherwise. You are advised to consult any further disclosures we make on related subjects in our reports on Form 10-Q, 8-K and 10-K that we provide to the Securities and Exchange Commission. Adjusted EPS 2006Y* 2007Y* 2008Y* 2009Y* 2010Y 2011Y 2012Y 2013Y 2014 Q2 Net income attributable to PolyOne common shareholders $ 130.9 $ 40.9 $ (417.0) $ 106.7 $ 152.5 $ 153.4 $ 53.3 $ 94.0 $ 60.3 Joint venture equity earnings, after tax (68.5) (26.1) (20.8) (19.0) (14.7) (3.7) - - - Special items, after tax (21.2) 41.4 310.0 (31.0) 15.8 (30.5) 35.7 30.4 36.7 Tax adjustments (30.0) (30.7) 147.2 (44.9) (88.3) (42.3) 0.5 2.2 (6.8) Adjusted net income $ 11.2 $ 25.5 $ 19.4 $ 11.8 $ 65.3 $ 76.9 $ 89.5 $ 126.6 $ 90.2 Diluted shares 92.8 93.1 92.7 93.4 96.0 94.3 89.8 96.5 94.9 Adjusted EPS $ 0.12 $ 0.27 $ 0.21 $ 0.13 $ 0.68 $ 0.82 $ 1.00 $ 1.31 $ 0.95 * Historical results are shown as presented in prior filings and have not been updated to reflect subsequent changes in accounting principal or discontinued operations.

We understand the challenges you face and are ready to help you bring your next-generation designs to life. AVIENT’S NO SURPRISES PLEDGE℠ At Avient, we are committed to helping you grow your business with safe and environmentally sound solutions. You have the responsibility to conduct full-scale end-product performance testing to determine suitability in your application, and you assume all risk and liability arising from your use of the information and/or use or handling of any product.

MEDICAL, FOOD AND TOY REGULATIONS Omnicolor colorants have limited EU food contact compliance, and are not suitable for FDA primary pharmaceutical packaging, cosmetic or medical applications. It is highly recommended to check with suppliers before using any Omnicolor masterbatch for food contact applications. You have the responsibility to conduct full-scale end-product performance testing to determine suitability in your application, and you assume all risk and liability arising from your use of the information and/or use or handling of any product.

Thanks to our talented associates and strategic portfolio investments, we have navigated the unprecedented challenges of the pandemic. added, "We will provide more details on our upcoming webcast, but our headline projection for 2021 is that we expect revenue growth of approximately 8% pro forma will drive adjusted EPS expansion from You are advised to consult any further disclosures we make on related subjects in our reports on Form 10-Q, 8-K and 10-K that we provide to the

Traditional steel coil and elastomeric springs have a few shortcomings. Make the switch to Avient’s thermoset composite springs, engineered with our proprietary resin/ fiber reinforcement technologies, to achieve long lasting, consistent performance in a variety of vibratory conveyor applications: • High strength-to-weight ratio—less than half the weight of steel • Long-term corrosion resistance • Exceptional fatigue resistance to withstand billions of cycles • Deep deflection • Excellent interlaminar shear strength • Creep resistance • Minimal work hardening • Static electricity control • Anti-microbial finishes for sanitary environments With extensive experience in composite spring technology, a wide range of rectangular sizes, and rapid, customized product development capabilities, we can help you optimize your industrial equipment for reliable, repeatable, efficient performance. You have the responsibility to conduct full-scale end-product performance testing to determine suitability in your application, and you assume all risk and liability arising from your use of the information and/or use or handling of any product.

CDP SCORE REPORT - CLIMATE CHANGE 2021 Your CDP score Average performance B C C B- Trading, wholesale, distribution, rental & leasing North America Global Average CDP SCORE REPORT - CLIMATE CHANGE 2021 CATEGORY SCORES If a company scored C or below, they will not have been scored for management or leadership points (the dark purple line represents this). Some categories have not been included for category score breakdown as either not enough questions feed into these categories to give a representative score or they are not scored at Management and Leadership levels. Scenario analysis No, but we anticipate using qualitative and/or quantitative analysis in the next two years https://6fefcbb86e61af1b2fc4-c70d8ead6ced550b4d987d7c03fcdd1d.ssl.cf3.rackcdn.com/cms/guidance_docs/pdfs/000/000/233/original/Scoring-Introduction.pdf?

CDP SCORE REPORT - CLIMATE CHANGE 2021 Your CDP score Average performance B C C B- Trading, wholesale, distribution, rental & leasing North America Global Average CDP SCORE REPORT - CLIMATE CHANGE 2021 CATEGORY SCORES If a company scored C or below, they will not have been scored for management or leadership points (the dark purple line represents this). Some categories have not been included for category score breakdown as either not enough questions feed into these categories to give a representative score or they are not scored at Management and Leadership levels. Scenario analysis No, but we anticipate using qualitative and/or quantitative analysis in the next two years https://6fefcbb86e61af1b2fc4-c70d8ead6ced550b4d987d7c03fcdd1d.ssl.cf3.rackcdn.com/cms/guidance_docs/pdfs/000/000/233/original/Scoring-Introduction.pdf?

Metal springs have a few shortcomings. Make the switch to Avient’s thermoset composite springs, made with our proprietary resin/fiber reinforcement technologies, to gain value in a variety of furniture spring applications: • Superior overall performance • Long term corrosion resistance • High fatigue strength • Deep deflection • Excellent inter-laminar shear strength • Creep resistance • Minimal work hardening • Consistent, repeatable cycles for a lifetime of use With extensive experience in composite spring technology, a wide range of rectangular sizes, and rapid, customized product development capabilities, we can help you create durable, reliable and cost-effective furniture for indoor or outdoor use. You have the responsibility to conduct full-scale end-product performance testing to determine suitability in your application, and you assume all risk and liability arising from your use of the information and/or use or handling of any product.

You have the responsibility to conduct full-scale end-product performance testing to determine suitability in your application, and you assume all risk and liability arising from your use of the information and/or use or handling of any product. As part of our commitment, we publish Avient’s Mevopur™ product policy and use limitations to assist customers in their product selection. Please be aware that there are certain applications Avient’s Mevopur products have not been designed for, nor are they promoted or intended for use in: including, but not limited to long-term or permanent implants, birth control devices, or plastic surgery.

You have the responsibility to conduct full-scale end-product performance testing to determine suitability in your application, and you assume all risk and liability arising from your use of the information and/or use or handling of any product. As part of our commitment, we publish Avient’s Mevopur™ product policy and use limitations to assist customers in their product selection. Please be aware that there are certain applications Avient’s Mevopur products have not been designed for, nor are they promoted or intended for use in: including, but not limited to long-term or permanent implants, birth control devices, or plastic surgery.